medicine
Thursday, October 17, 2024
Weimar – Experts from research, clinical practice and the pharmaceutical industry have jointly called for more incentives for the development and marketing of new resistance-breaking antibiotics. The problem is that the new antibiotics should be prescribed only very restrictively so that resistance to them does not develop, a press conference at the annual meeting of the Paul Ehrlich Society for Infectious Diseases in Weimar was told today. This leads…